John Anderson
Corporate Officer/Principal presso The Royal College of Physicians
Provenienza dei contatti di primo grado di John Anderson
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
The Royal College of Physicians
117
| College/University | Other Consumer Services | 117 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a John Anderson tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of Hong Kong | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
University of Cambridge | College/University | Doctorate Degree Masters Business Admin Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
National University of Singapore | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
University of London | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
The University of Edinburgh | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
University College London | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Imperial College London | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Undergraduate Degree | |
Faculty of Pharmaceutical Medicine | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | ||
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
The Royal College of Paediatrics & Child Health | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
The University of Manchester | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of Oxford | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
University of Malaya | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
University of Leeds | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
OXFORD BIOMEDICA PLC | Biotechnology | President Corporate Officer/Principal Corporate Officer/Principal | |
University of Glasgow | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Singapore Cancer Centre Pte Ltd.
Singapore Cancer Centre Pte Ltd. Hospital/Nursing ManagementHealth Services Singapore Cancer Centre Pte Ltd. provides oncology services. The Singaporean company was founded by Kei Siong Khoo. | Hospital/Nursing Management | Director/Board Member Founder | |
Parkway Cancer Centre
Parkway Cancer Centre Hospital/Nursing ManagementHealth Services Parkway Cancer Centre engages in cancer treatment activities. Its services include medical, surgical and haematology and radiation oncology, palliative medicine, and cancer screening. The company was founded by Peng Tiam Ang, Teo Cheng Peng, Khoo Kei Siong, and Lim Hong Liang in 2006 and is headquartered in Singapore. | Hospital/Nursing Management | Founder Founder | |
TALKMED GROUP LIMITED | Medical/Nursing Services | Chief Executive Officer Chief Operating Officer | |
Charing Cross Hospital Medical School | College/University | Doctorate Degree Graduate Degree | |
SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
ICON PUBLIC LIMITED COMPANY | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Hong Kong College of Physicians
Hong Kong College of Physicians Miscellaneous Commercial ServicesCommercial Services The Hong Kong College of Physicians operates an association of physicians. The private company is based in Hong Kong, Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Hong Kong Medical Association | Corporate Officer/Principal Corporate Officer/Principal | ||
SANGAMO THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ATHENEXPAR | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal | |
The Chinese University of Hong Kong | College/University | Graduate Degree Undergraduate Degree | |
Trinity College Dublin | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Royal Free Hospital Medical School | College/University | Doctorate Degree Doctorate Degree | |
Haematology & Cancer Centre Pte Ltd. | Director/Board Member Director/Board Member | ||
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Regno Unito | 19 |
Stati Uniti | 16 |
Singapore | 6 |
Hong Kong | 5 |
Irlanda | 3 |
Settori
Health Technology | 22 |
Consumer Services | 19 |
Health Services | 6 |
Commercial Services | 3 |
Finance | 2 |
Posizioni
Director/Board Member | 541 |
Corporate Officer/Principal | 354 |
Chief Tech/Sci/R&D Officer | 139 |
Independent Dir/Board Member | 86 |
Chairman | 74 |
Contatti più connessi
Insiders | |
---|---|
Cheok Peng Lim | 128 |
Chrisantha Nicholas Nonis | 47 |
Tong Choon Cheo | 44 |
Frank Armstrong | 41 |
Martin Edwards | 38 |
Freda Lewis-Hall | 29 |
Ik King Tiong | 29 |
Peng Tiam Ang | 26 |
Yiu Nam Lau | 26 |
Preetinder Singh Joshi | 23 |
Paul Blake | 23 |
Kei Siong Khoo | 23 |
James Shannon | 22 |
David J. Clark | 21 |
Lesley Russell | 19 |
- Borsa valori
- Insiders
- John Anderson
- Connessioni Società